Identification of Valeriana fauriei and other Eurasian medicinal valerian by DNA polymorphisms in psbA–trnH intergenic spacer sequences in chloroplast DNA

Taichi Fujii,Takako Mori,Yoshiaki Tatsuo,Yasumasa Takao,Hiroharu Fujino,Takashi Tsuchida,Motoyasu Minami

DOI: https://doi.org/10.1007/s11418-021-01488-z

IF: 3.1921

2021-02-25

Journal of Natural Medicines

Abstract:In order to differentiate among <i>Valeriana fauriei</i> Briq. and other Eurasian medicinal valerian (<i>V</i>. <i>dioica</i> L., <i>V</i>. <i>hardwickii</i> Wall., <i>V</i>. <i>jatamansi</i> Jones, and <i>V</i>. <i>officinalis</i> L.), we attempted to establish DNA markers. DNA sequences for the <i>psb</i>A–<i>trn</i>H intergenic spacer region of chloroplast DNA (<i>psb</i>A–<i>trn</i>H) and 18S ribosomal RNA, internal transcribed spacer 1 (ITS1), 5.8S ribosomal RNA, internal transcribed spacer 2 (ITS2), and 28S ribosomal RNA of nuclear DNA in <i>V. fauriei</i> and other Eurasian medicinal valerian were compared. Using partial sequences of <i>psb</i>A–<i>trn</i>H (nucleotide positions 1–75 from the 5′ end of the intergenic spacer region), <i>V. fauriei</i> and other Eurasian medicinal valerian could be correctly identified to the species level. In addition, the partial sequences of <i>psb</i>A–<i>trn</i>H in <i>V. fauriei</i> contained five different haplotypes, and it was possible to distinguish the origins of valerian from Japan and Eurasia (China and Korea). On the other hand, individuals had heterogeneous sequences of ITS1 and ITS2, making it impossible to use direct sequencing and DNA markers of ITS1 and ITS2 to distinguish species and origins of <i>V. fauriei</i> and other Eurasian medicinal valerian.

pharmacology & pharmacy,chemistry, medicinal